Analyst ratings, especially from reputable firms like RBC Capital, can significantly influence investor sentiment and stock prices. An Outperform rating combined with a high price target suggests a strong bullish outlook for Jasper Therapeutics, likely leading to increased investor interest and potentially a rise in stock price in the short term.